Illumina ILMN
NASDAQ ILMN
$245.18 +16.25 (+7.10%)
At close: Sep 17, 2026 · 4:00 PM EDT

Illumina (ILMN) Income from Non-Controlling Interests (2015 - 2019)

Illumina's (ILMN) quarterly Income from Non-Controlling Interests came in at -$3.0 million in Q2 2019, up 66.67% on a YoY basis from -$1.8 million in Q2 2018, and up 66.67% quarter-over-quarter from -$9.0 million in Q1 2019.

Analysis

Illumina (ILMN) Income from Non-Controlling Interests (2015 - 2019) Analysis & Trends

Illumina (ILMN) has reported Income from Non-Controlling Interests for 5 consecutive years, with -$3.0 million the latest figure, recorded in Q2 2019.

  • For the quarter ending Q2 2019, Income from Non-Controlling Interests rose 66.67% year-over-year to -$3.0 million; the trailing twelve-month figure through Mar 2020 stood at -$3.0 million (up 92.86% YoY), and the FY2019 full-year result was -$12.0 million, up 72.73% from the prior year.
  • Income from Non-Controlling Interests grew to -$3.0 million in Q2 2019 per ILMN's latest filing, from -$9.0 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at -$1.6 million in Q1 2016 and bottomed at -$19.0 million in Q2 2017.
  • Historically, Income from Non-Controlling Interests has averaged -$8.5 million across 5 years, with a median of -$9.0 million in 2018.
  • The sharpest annual moves came in 2017 and 2019: Income from Non-Controlling Interests plunged 850.0% in 2017, then soared 66.67% in 2019.
  • Over 5 years, Income from Non-Controlling Interests stood at -$2.6 million in 2015, then sank by 369.48% to -$12.0 million in 2016, then increased by 8.33% to -$11.0 million in 2017, then fell by 18.18% to -$13.0 million in 2018, then surged by 76.92% to -$3.0 million in 2019.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered -$3.0 million, -$9.0 million, and -$13.0 million for Q2 2019, Q1 2019, and Q4 2018 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 5.00 Mn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn -
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 1.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 -3.00 Mn
Mar 31, 2019 -9.00 Mn
Dec 30, 2018 -13.00 Mn
Sep 30, 2018 -11.00 Mn
Jul 1, 2018 -9.00 Mn
Apr 1, 2018 -11.00 Mn
Dec 31, 2017 -11.00 Mn
Oct 1, 2017 -11.00 Mn
Jul 2, 2017 -8.00 Mn
Apr 2, 2017 -19.00 Mn
Oct 2, 2016 -12.00 Mn
Jul 3, 2016 -4.00 Mn
Apr 3, 2016 -2.00 Mn
Jan 3, 2016 -1.61 Mn
Sep 27, 2015 -2.56 Mn